ECI Pharmaceuticals LLC Signs Agreement to Be Exclusive U.S. Distributor of Generic Cialis®
Fort Lauderdale, Fla., May 10, 2021 – ECI Pharmaceuticals, LLC (ECI) today announced that it has entered into an exclusive U.S. agreement with Qilu Pharmaceutical Co., Ltd. (Qilu) to manage the sales, marketing, and distribution for the therapeutically equivalent generic of Cialis®, with strengths of 2.5mg, 5mg, 10mg, 20mg tablets. Cialis®, and the generic equivalent…